Literature DB >> 27611563

Antibiotic Potency against E. coli Is Enhanced by Channel-Forming Alkyl Lariat Ethers.

Saeedeh Negin1,2, Mohit B Patel3,2, Michael R Gokel2, Joseph W Meisel4,1, George W Gokel4,1,3,2.   

Abstract

Several N,N'-bis(n-alkyl-4,13-diaza[18]crown-6) lariat ethers were found to significantly enhance the potency of rifampicin and tetracycline, but not erythromycin and kanamycin, against the non-pathogenic DH5α and K-12 strains of Escherichia coli when administered at levels below their minimum inhibitory concentrations (MICs). The enhancements in antibiotic potency observed for the lariat ethers ranged from three- to 20-fold, depending on the strain of E. coli, the antibiotic, and the lengths of the alkyl chains attached at the macroring nitrogen atoms. The dialkyl lariat ethers, previously thought to only be cation carriers, formed well-behaved, ion-conducting pores in soybean asolectin membranes, as judged by planar bilayer conductance measurements. The ability of lariat ethers to form stable pores, which appeared to be aggregated, depended in part on alkyl chain length and in part on the composition of the bilayer membrane in which they were studied.
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; channel function; lariat ethers; planar bilayer conductance; pore formation

Mesh:

Substances:

Year:  2016        PMID: 27611563     DOI: 10.1002/cbic.201600428

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  2 in total

1.  Acylated and alkylated benzo(crown-ethers) form ion-dependent ion channels in biological membranes.

Authors:  Willy Carrasquel-Ursulaez; Mahzad Dehghany; Corey L Jones; Vinaykumar Idikuda; Brian Lu; Jennifer M Schomaker; Baron Chanda
Journal:  Biophys J       Date:  2022-02-02       Impact factor: 4.033

2.  Re-evaluation of the mechanism of cytotoxicity of dialkylated lariat ether compounds.

Authors:  Willy Carrasquel-Ursulaez; Ryan D Reeves; Mahzad Dehghany; Corey Jones; Jennifer M Schomaker; Baron Chanda
Journal:  RSC Adv       Date:  2020-11-05       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.